The United Laboratories International Holdings Limited (FRA:UNJ)

Market Cap	2.09B -32.1%
Revenue (ttm)	1.61B -4.0%
Net Income	254.00M -21.6%
EPS	0.13 -24.4%
Shares Out	n/a
PE Ratio	8.24
Forward PE	10.56
Dividend	0.07 (6.48%)
Ex-Dividend Date	Sep 25, 2025

Volume	n/a
Average Volume	13
Open	1.050
Previous Close	1.030
Day's Range	1.050 - 1.050
52-Week Range	1.030 - 1.870
Beta	n/a
RSI	38.27
Earnings Date	May 28, 2026

About FRA:UNJ

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 18,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UNJ

Financial Performance

In 2025, FRA:UNJ's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY